Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis

被引：0
|
作者：
Matos, Sara [1 ]
Cunha, Carolina [1 ]
Bernardes, Catarina [1 ]
Cardoso, Joao [2 ]
Campelo, Isabel [2 ]
Feio, Jose [2 ]
Batista, Sonia [1 ,3 ]
Nunes, Carla [1 ]
Macario, Maria do Carmo [1 ,3 ]
Sousa, Livia Maria [1 ,3 ]
Correia, Ines [1 ,3 ]
机构：
[1] Coimbra Univ Hosp Ctr, Neurol, Coimbra, Portugal
[2] Coimbra Univ Hosp Ctr, Hosp Pharm, Coimbra, Portugal
[3] Coimbra Univ, Fac Med, Coimbra, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1464/1365
引用
收藏
页码：931 / 931
页数：1
相关论文
共 50 条
  • [21] Switching Therapies in Multiple Sclerosis
    Patricia K. Coyle
    CNS Drugs, 2013, 27 : 239 - 247
  • [22] Switching Therapies in Multiple Sclerosis
    Coyle, Patricia K.
    CNS DRUGS, 2013, 27 (04) : 239 - 247
  • [23] Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
    Jan D. Lünemann
    Tobias Ruck
    Paolo A. Muraro
    Amit Bar-Or
    Heinz Wiendl
    Nature Reviews Neurology, 2020, 16 : 125 - 125
  • [24] Multiple sclerosis: Investigation into side effects of switching patients to natalizumab biosimilar
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [25] Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome (IRIS) in a Multiple Sclerosis Patient Taking Natalizumab
    Valenzuela, Reuben
    Pula, John
    Garwacki, Dennis
    Kattah, Jorge
    NEUROLOGY, 2013, 80
  • [26] Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
    Hoepner, Robert
    Havla, Joachim
    Eienbroeker, Christian
    Tackenberg, Bjoern
    Hellwig, Kerstin
    Meinl, Ingrid
    Hohlfeld, Reinhard
    Gold, Ralf
    Kuempfel, Tania
    Kleiter, Ingo
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (13) : 1714 - 1720
  • [27] Switching From Natalizumab to Fingolimod in Multiple Sclerosis A French Prospective Study
    Cohen, Mikael
    Maillart, Elisabeth
    Tourbah, Ayman
    De Seze, Jerome
    Vukusic, Sandra
    Brassat, David
    Anne, Olivier
    Wiertlewski, Sandrine
    Camu, William
    Courtois, Vie
    Ruet, Aurelie
    Debouverie, Marc
    Le Page, Emmanuelle
    Casez, Olivier
    Heinzlef, Olivier
    Stankoff, Bruno
    Bourre, Bertrand
    Castelnovo, Giovanni
    Rico, Audrey
    Berger, Eric
    Camdessanche, Jean-Philippe
    Defer, Gilles
    Clavelou, Pierre
    Al Khedr, Abdullatif
    Zephir, Helene
    Fromont, Agnes
    Papeix, Caroline
    Brochet, Bruno
    Pelletier, Jean
    Lebrun, Christine
    JAMA NEUROLOGY, 2014, 71 (04) : 436 - 441
  • [28] Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis
    Fakih, Ali Ussama
    Sahraian, Mohammad Ali
    Paybast, Sepideh
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 71
  • [29] Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
    Metz, Imke
    Radue, Ernst-Wilhelm
    Oterino, Agustin
    Kuempfel, Tania
    Wiendl, Heinz
    Schippling, Sven
    Kuhle, Jens
    Sahraian, Mohammad Ali
    Gray, Francoise
    Jakl, Veronika
    Haeusler, Darius
    Brueck, Wolfgang
    ACTA NEUROPATHOLOGICA, 2012, 123 (02) : 235 - 245
  • [30] Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
    Imke Metz
    Ernst-Wilhelm Radue
    Agustin Oterino
    Tania Kümpfel
    Heinz Wiendl
    Sven Schippling
    Jens Kuhle
    Mohammad Ali Sahraian
    Francoise Gray
    Veronika Jakl
    Darius Häusler
    Wolfgang Brück
    Acta Neuropathologica, 2012, 123 : 235 - 245
12345